 | • レポートコード：MRC2-11QY12314 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は免疫蛍光アッセイのグローバル市場について調査・分析したレポートです。種類別（間接免疫蛍光法、直接免疫蛍光法）市場規模、用途別（がん、感染症、自己免疫疾患、心血管疾患、その他疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別免疫蛍光アッセイの競争状況、市場シェア ・世界の免疫蛍光アッセイ市場：種類別市場規模 2015年-2020年（間接免疫蛍光法、直接免疫蛍光法） ・世界の免疫蛍光アッセイ市場：種類別市場規模予測 2021年-2026年（間接免疫蛍光法、直接免疫蛍光法） ・世界の免疫蛍光アッセイ市場：用途別市場規模 2015年-2020年（がん、感染症、自己免疫疾患、心血管疾患、その他疾患） ・世界の免疫蛍光アッセイ市場：用途別市場規模予測 2021年-2026年（がん、感染症、自己免疫疾患、心血管疾患、その他疾患） ・北米の免疫蛍光アッセイ市場分析：米国、カナダ ・ヨーロッパの免疫蛍光アッセイ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの免疫蛍光アッセイ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の免疫蛍光アッセイ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの免疫蛍光アッセイ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Thermo Fisher、Abcam、Bio-Rad Laboratories、Perkinelmer、Merck Millipore、Inova Diagnostics、Cell Signaling Technology、Medipan、Sino Biological、Danaher、Vector Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Immunofluorescence Assay(IFA) is a traditional laboratory technique that utilizes fluorescent dyes to identify the presence of antibodies bound to specific antigens. The IFA is very useful to detect the serologic response of a patient who has been exposed to certain infectious agents.
In 2017, the indirect immunofluorescence accounted for the largest share of the market. The advantages of this technique, such as its sensitivity, flexibility, better amplification of the signal, and lower cost over direct immunofluorescence is the key factor increasing the adoption of this technique.
Market Analysis and Insights: Global Immunofluorescence Assay Market
The global Immunofluorescence Assay market size is projected to reach US$ 1404.6 million by 2026, from US$ 1336.7 million in 2020, at a CAGR of 4.7%% during 2021-2026.
Global Immunofluorescence Assay Scope and Market Size
Immunofluorescence Assay market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunofluorescence Assay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Thermo Fisher
Abcam
Bio-Rad Laboratories
Perkinelmer
Merck Millipore
Inova Diagnostics
Cell Signaling Technology
Medipan
Sino Biological
Danaher
Vector Laboratories
Market segment by Type, the product can be split into
Indirect Immunofluorescence
Direct Immunofluorescence
Market segment by Application, split into
Cancer
Infectious Diseases
Autoimmune Diseases
Cardiovascular Diseases
Other Diseases
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immunofluorescence Assay Revenue
1.4 Market by Type
1.4.1 Global Immunofluorescence Assay Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Indirect Immunofluorescence
1.4.3 Direct Immunofluorescence
1.5 Market by Application
1.5.1 Global Immunofluorescence Assay Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Infectious Diseases
1.5.4 Autoimmune Diseases
1.5.5 Cardiovascular Diseases
1.5.6 Other Diseases
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Immunofluorescence Assay Market Perspective (2015-2026)
2.2 Global Immunofluorescence Assay Growth Trends by Regions
2.2.1 Immunofluorescence Assay Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immunofluorescence Assay Historic Market Share by Regions (2015-2020)
2.2.3 Immunofluorescence Assay Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Immunofluorescence Assay Market Growth Strategy
2.3.6 Primary Interviews with Key Immunofluorescence Assay Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Immunofluorescence Assay Players by Market Size
3.1.1 Global Top Immunofluorescence Assay Players by Revenue (2015-2020)
3.1.2 Global Immunofluorescence Assay Revenue Market Share by Players (2015-2020)
3.1.3 Global Immunofluorescence Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immunofluorescence Assay Market Concentration Ratio
3.2.1 Global Immunofluorescence Assay Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immunofluorescence Assay Revenue in 2019
3.3 Immunofluorescence Assay Key Players Head office and Area Served
3.4 Key Players Immunofluorescence Assay Product Solution and Service
3.5 Date of Enter into Immunofluorescence Assay Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunofluorescence Assay Historic Market Size by Type (2015-2020)
4.2 Global Immunofluorescence Assay Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Immunofluorescence Assay Market Size by Application (2015-2020)
5.2 Global Immunofluorescence Assay Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Immunofluorescence Assay Market Size (2015-2020)
6.2 Immunofluorescence Assay Key Players in North America (2019-2020)
6.3 North America Immunofluorescence Assay Market Size by Type (2015-2020)
6.4 North America Immunofluorescence Assay Market Size by Application (2015-2020)
7 Europe
7.1 Europe Immunofluorescence Assay Market Size (2015-2020)
7.2 Immunofluorescence Assay Key Players in Europe (2019-2020)
7.3 Europe Immunofluorescence Assay Market Size by Type (2015-2020)
7.4 Europe Immunofluorescence Assay Market Size by Application (2015-2020)
8 China
8.1 China Immunofluorescence Assay Market Size (2015-2020)
8.2 Immunofluorescence Assay Key Players in China (2019-2020)
8.3 China Immunofluorescence Assay Market Size by Type (2015-2020)
8.4 China Immunofluorescence Assay Market Size by Application (2015-2020)
9 Japan
9.1 Japan Immunofluorescence Assay Market Size (2015-2020)
9.2 Immunofluorescence Assay Key Players in Japan (2019-2020)
9.3 Japan Immunofluorescence Assay Market Size by Type (2015-2020)
9.4 Japan Immunofluorescence Assay Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Immunofluorescence Assay Market Size (2015-2020)
10.2 Immunofluorescence Assay Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immunofluorescence Assay Market Size by Type (2015-2020)
10.4 Southeast Asia Immunofluorescence Assay Market Size by Application (2015-2020)
11 India
11.1 India Immunofluorescence Assay Market Size (2015-2020)
11.2 Immunofluorescence Assay Key Players in India (2019-2020)
11.3 India Immunofluorescence Assay Market Size by Type (2015-2020)
11.4 India Immunofluorescence Assay Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Immunofluorescence Assay Market Size (2015-2020)
12.2 Immunofluorescence Assay Key Players in Central & South America (2019-2020)
12.3 Central & South America Immunofluorescence Assay Market Size by Type (2015-2020)
12.4 Central & South America Immunofluorescence Assay Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Details
13.1.2 Thermo Fisher Business Overview
13.1.3 Thermo Fisher Immunofluorescence Assay Introduction
13.1.4 Thermo Fisher Revenue in Immunofluorescence Assay Business (2015-2020))
13.1.5 Thermo Fisher Recent Development
13.2 Abcam
13.2.1 Abcam Company Details
13.2.2 Abcam Business Overview
13.2.3 Abcam Immunofluorescence Assay Introduction
13.2.4 Abcam Revenue in Immunofluorescence Assay Business (2015-2020)
13.2.5 Abcam Recent Development
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Details
13.3.2 Bio-Rad Laboratories Business Overview
13.3.3 Bio-Rad Laboratories Immunofluorescence Assay Introduction
13.3.4 Bio-Rad Laboratories Revenue in Immunofluorescence Assay Business (2015-2020)
13.3.5 Bio-Rad Laboratories Recent Development
13.4 Perkinelmer
13.4.1 Perkinelmer Company Details
13.4.2 Perkinelmer Business Overview
13.4.3 Perkinelmer Immunofluorescence Assay Introduction
13.4.4 Perkinelmer Revenue in Immunofluorescence Assay Business (2015-2020)
13.4.5 Perkinelmer Recent Development
13.5 Merck Millipore
13.5.1 Merck Millipore Company Details
13.5.2 Merck Millipore Business Overview
13.5.3 Merck Millipore Immunofluorescence Assay Introduction
13.5.4 Merck Millipore Revenue in Immunofluorescence Assay Business (2015-2020)
13.5.5 Merck Millipore Recent Development
13.6 Inova Diagnostics
13.6.1 Inova Diagnostics Company Details
13.6.2 Inova Diagnostics Business Overview
13.6.3 Inova Diagnostics Immunofluorescence Assay Introduction
13.6.4 Inova Diagnostics Revenue in Immunofluorescence Assay Business (2015-2020)
13.6.5 Inova Diagnostics Recent Development
13.7 Cell Signaling Technology
13.7.1 Cell Signaling Technology Company Details
13.7.2 Cell Signaling Technology Business Overview
13.7.3 Cell Signaling Technology Immunofluorescence Assay Introduction
13.7.4 Cell Signaling Technology Revenue in Immunofluorescence Assay Business (2015-2020)
13.7.5 Cell Signaling Technology Recent Development
13.8 Medipan
13.8.1 Medipan Company Details
13.8.2 Medipan Business Overview
13.8.3 Medipan Immunofluorescence Assay Introduction
13.8.4 Medipan Revenue in Immunofluorescence Assay Business (2015-2020)
13.8.5 Medipan Recent Development
13.9 Sino Biological
13.9.1 Sino Biological Company Details
13.9.2 Sino Biological Business Overview
13.9.3 Sino Biological Immunofluorescence Assay Introduction
13.9.4 Sino Biological Revenue in Immunofluorescence Assay Business (2015-2020)
13.9.5 Sino Biological Recent Development
13.10 Danaher
13.10.1 Danaher Company Details
13.10.2 Danaher Business Overview
13.10.3 Danaher Immunofluorescence Assay Introduction
13.10.4 Danaher Revenue in Immunofluorescence Assay Business (2015-2020)
13.10.5 Danaher Recent Development
13.11 Vector Laboratories
10.11.1 Vector Laboratories Company Details
10.11.2 Vector Laboratories Business Overview
10.11.3 Vector Laboratories Immunofluorescence Assay Introduction
10.11.4 Vector Laboratories Revenue in Immunofluorescence Assay Business (2015-2020)
10.11.5 Vector Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Immunofluorescence Assay Key Market Segments
Table 2. Key Players Covered: Ranking by Immunofluorescence Assay Revenue
Table 3. Ranking of Global Top Immunofluorescence Assay Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immunofluorescence Assay Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Indirect Immunofluorescence
Table 6. Key Players of Direct Immunofluorescence
Table 7. Global Immunofluorescence Assay Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Immunofluorescence Assay Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Immunofluorescence Assay Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Immunofluorescence Assay Market Share by Regions (2015-2020)
Table 11. Global Immunofluorescence Assay Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Immunofluorescence Assay Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Immunofluorescence Assay Market Growth Strategy
Table 17. Main Points Interviewed from Key Immunofluorescence Assay Players
Table 18. Global Immunofluorescence Assay Revenue by Players (2015-2020) (Million US$)
Table 19. Global Immunofluorescence Assay Market Share by Players (2015-2020)
Table 20. Global Top Immunofluorescence Assay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunofluorescence Assay as of 2019)
Table 21. Global Immunofluorescence Assay by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immunofluorescence Assay Product Solution and Service
Table 24. Date of Enter into Immunofluorescence Assay Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immunofluorescence Assay Market Size by Type (2015-2020) (Million US$)
Table 27. Global Immunofluorescence Assay Market Size Share by Type (2015-2020)
Table 28. Global Immunofluorescence Assay Revenue Market Share by Type (2021-2026)
Table 29. Global Immunofluorescence Assay Market Size Share by Application (2015-2020)
Table 30. Global Immunofluorescence Assay Market Size by Application (2015-2020) (Million US$)
Table 31. Global Immunofluorescence Assay Market Size Share by Application (2021-2026)
Table 32. North America Key Players Immunofluorescence Assay Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Immunofluorescence Assay Market Share (2019-2020)
Table 34. North America Immunofluorescence Assay Market Size by Type (2015-2020) (Million US$)
Table 35. North America Immunofluorescence Assay Market Share by Type (2015-2020)
Table 36. North America Immunofluorescence Assay Market Size by Application (2015-2020) (Million US$)
Table 37. North America Immunofluorescence Assay Market Share by Application (2015-2020)
Table 38. Europe Key Players Immunofluorescence Assay Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Immunofluorescence Assay Market Share (2019-2020)
Table 40. Europe Immunofluorescence Assay Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Immunofluorescence Assay Market Share by Type (2015-2020)
Table 42. Europe Immunofluorescence Assay Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Immunofluorescence Assay Market Share by Application (2015-2020)
Table 44. China Key Players Immunofluorescence Assay Revenue (2019-2020) (Million US$)
Table 45. China Key Players Immunofluorescence Assay Market Share (2019-2020)
Table 46. China Immunofluorescence Assay Market Size by Type (2015-2020) (Million US$)
Table 47. China Immunofluorescence Assay Market Share by Type (2015-2020)
Table 48. China Immunofluorescence Assay Market Size by Application (2015-2020) (Million US$)
Table 49. China Immunofluorescence Assay Market Share by Application (2015-2020)
Table 50. Japan Key Players Immunofluorescence Assay Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Immunofluorescence Assay Market Share (2019-2020)
Table 52. Japan Immunofluorescence Assay Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Immunofluorescence Assay Market Share by Type (2015-2020)
Table 54. Japan Immunofluorescence Assay Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Immunofluorescence Assay Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Immunofluorescence Assay Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Immunofluorescence Assay Market Share (2019-2020)
Table 58. Southeast Asia Immunofluorescence Assay Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Immunofluorescence Assay Market Share by Type (2015-2020)
Table 60. Southeast Asia Immunofluorescence Assay Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Immunofluorescence Assay Market Share by Application (2015-2020)
Table 62. India Key Players Immunofluorescence Assay Revenue (2019-2020) (Million US$)
Table 63. India Key Players Immunofluorescence Assay Market Share (2019-2020)
Table 64. India Immunofluorescence Assay Market Size by Type (2015-2020) (Million US$)
Table 65. India Immunofluorescence Assay Market Share by Type (2015-2020)
Table 66. India Immunofluorescence Assay Market Size by Application (2015-2020) (Million US$)
Table 67. India Immunofluorescence Assay Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Immunofluorescence Assay Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Immunofluorescence Assay Market Share (2019-2020)
Table 70. Central & South America Immunofluorescence Assay Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Immunofluorescence Assay Market Share by Type (2015-2020)
Table 72. Central & South America Immunofluorescence Assay Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Immunofluorescence Assay Market Share by Application (2015-2020)
Table 74. Thermo Fisher Company Details
Table 75. Thermo Fisher Business Overview
Table 76. Thermo Fisher Product
Table 77. Thermo Fisher Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 78. Thermo Fisher Recent Development
Table 79. Abcam Company Details
Table 80. Abcam Business Overview
Table 81. Abcam Product
Table 82. Abcam Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 83. Abcam Recent Development
Table 84. Bio-Rad Laboratories Company Details
Table 85. Bio-Rad Laboratories Business Overview
Table 86. Bio-Rad Laboratories Product
Table 87. Bio-Rad Laboratories Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 88. Bio-Rad Laboratories Recent Development
Table 89. Perkinelmer Company Details
Table 90. Perkinelmer Business Overview
Table 91. Perkinelmer Product
Table 92. Perkinelmer Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 93. Perkinelmer Recent Development
Table 94. Merck Millipore Company Details
Table 95. Merck Millipore Business Overview
Table 96. Merck Millipore Product
Table 97. Merck Millipore Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 98. Merck Millipore Recent Development
Table 99. Inova Diagnostics Company Details
Table 100. Inova Diagnostics Business Overview
Table 101. Inova Diagnostics Product
Table 102. Inova Diagnostics Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 103. Inova Diagnostics Recent Development
Table 104. Cell Signaling Technology Company Details
Table 105. Cell Signaling Technology Business Overview
Table 106. Cell Signaling Technology Product
Table 107. Cell Signaling Technology Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 108. Cell Signaling Technology Recent Development
Table 109. Medipan Business Overview
Table 110. Medipan Product
Table 111. Medipan Company Details
Table 112. Medipan Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 113. Medipan Recent Development
Table 114. Sino Biological Company Details
Table 115. Sino Biological Business Overview
Table 116. Sino Biological Product
Table 117. Sino Biological Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 118. Sino Biological Recent Development
Table 119. Danaher Company Details
Table 120. Danaher Business Overview
Table 121. Danaher Product
Table 122. Danaher Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 123. Danaher Recent Development
Table 124. Vector Laboratories Company Details
Table 125. Vector Laboratories Business Overview
Table 126. Vector Laboratories Product
Table 127. Vector Laboratories Revenue in Immunofluorescence Assay Business (2015-2020) (Million US$)
Table 128. Vector Laboratories Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunofluorescence Assay Market Share by Type: 2020 VS 2026
Figure 2. Indirect Immunofluorescence Features
Figure 3. Direct Immunofluorescence Features
Figure 4. Global Immunofluorescence Assay Market Share by Application: 2020 VS 2026
Figure 5. Cancer Case Studies
Figure 6. Infectious Diseases Case Studies
Figure 7. Autoimmune Diseases Case Studies
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Other Diseases Case Studies
Figure 10. Immunofluorescence Assay Report Years Considered
Figure 11. Global Immunofluorescence Assay Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Immunofluorescence Assay Market Share by Regions: 2020 VS 2026
Figure 13. Global Immunofluorescence Assay Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Immunofluorescence Assay Market Share by Players in 2019
Figure 16. Global Top Immunofluorescence Assay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunofluorescence Assay as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Immunofluorescence Assay Revenue in 2019
Figure 18. North America Immunofluorescence Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Immunofluorescence Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Immunofluorescence Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Immunofluorescence Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Immunofluorescence Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Immunofluorescence Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Immunofluorescence Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
動物用自己免疫疾患検査の世界市場（～2026年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…- 自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
- 酵素免疫測定法（ELISA）検査の世界市場（～2026年） Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Hospitals and diagnostic centers were the major end-users to the ELISA test market. The demand ELISA testing in this end-user segment is mainly due to factors …
- POC感染性疾患の世界市場（～2026年） POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted peri…
- 製薬用酸化ストレスアッセイの世界市場（～2026年） Oxidative stress refers to the imbalance between oxidation and antioxidation in the body, which tends to oxidize, leading to the inflammatory infiltration of neutrophils, the increase of protease secretion, and the production of a large number of oxidation intermediates. The increasing investments i…